Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imiquimod 5% cream in actinic keratosis in organ transplant recipients
NCT00189267Phase 2Completed
- Sponsor
- Meda
- Start
- Nov 2002
- Modality
- Nucleic Acid-Directed Small Molecules, Irreversible Covalent Inhibitors, Metabolically Activated Prodrugs
01
Overview
A Phase 2 trial of imiquimod in actinic keratosis (AK), sponsored by Meda. Started Nov 2002; status: completed.
02
Drugs
imiquimod
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT00189267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00189267.